Nath Bio-Genes (India) Limited
Fast Moving Consumer Goods›Fast Moving Consumer Goods›Agricultural Food & other Products›Other Agricultural Products
Key metrics
Price as of 2026-07-20
Sign in for full ratios and TTM. Learn about these metrics →
Share price
NSE closing price from historical market data.
Loading price history…
Statement tables · Consolidated
Switches quarterly, P&L, balance sheet, and cash flow. Key metrics and ratios stay on consolidated when available.
Amounts in ₹ Cr · NSE preferred when both exchanges report the same period · tap + to expand rows
Quarterly results
Quarterly · ₹ Cr · tap + rows to expand
| Metric | Mar 2023 | Jun 2023 | Sept 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sept 2024 | Dec 2024 | Jun 2025 | Sept 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 301 Cr | 235 Cr | 258 Cr | 290 Cr | 333 Cr | 244 Cr | 276 Cr | 37 Cr | 284 Cr | 44 Cr | 66 Cr | 52 Cr |
| Operating expenses (approx.) | 252 Cr | 198 Cr | 215 Cr | 239 Cr | 279 Cr | 207 Cr | 235 Cr | 28 Cr | 242 Cr | 34 Cr | 58 Cr | 43 Cr |
| EBITDA | 49 Cr | 37 Cr | 42 Cr | 50 Cr | 54 Cr | 37 Cr | 42 Cr | 9 Cr | 42 Cr | 10 Cr | 8 Cr | 8 Cr |
| OPM % | 16.4% | 15.7% | 16.4% | 17.3% | 16.2% | 15.0% | 15.1% | 23.1% | 14.8% | 23.0% | 12.1% | 15.7% |
| Other income | 0.55 Cr | 0.12 Cr | 0.18 Cr | 0.22 Cr | 0.63 Cr | 0.13 Cr | 0.21 Cr | 0.48 Cr | 2 Cr | 2 Cr | 2 Cr | 2 Cr |
| Interest | 10 Cr | 3 Cr | 5 Cr | 8 Cr | 9 Cr | 2 Cr | 5 Cr | 4 Cr | 3 Cr | 4 Cr | 5 Cr | 5 Cr |
| Depreciation | 3 Cr | 0.76 Cr | 2 Cr | 2 Cr | 3 Cr | 0.82 Cr | 2 Cr | 0.82 Cr | 0.97 Cr | 0.99 Cr | 0.98 Cr | 1 Cr |
| Profit before tax | 36 Cr | 33 Cr | 36 Cr | 40 Cr | 42 Cr | 34 Cr | 35 Cr | 4 Cr | 38 Cr | 5 Cr | 2 Cr | 2 Cr |
| Tax % | 3.2% | 0.7% | 1.6% | 3.3% | 4.7% | 0.7% | 0.6% | 30.1% | 1.7% | 11.7% | 35.2% | 100.4% |
| Net profit | 35 Cr | 33 Cr | 35 Cr | 39 Cr | 40 Cr | 33 Cr | 34 Cr | 3 Cr | 37 Cr | 3 Cr | 2 Cr | -0.0092 Cr |
| EPS (₹) | ₹18.42 | ₹17.47 | ₹18.27 | ₹20.29 | ₹21.34 | ₹17.49 | ₹18.01 | ₹1.33 | ₹19.58 | ₹1.40 | ₹0.84 | ₹-0.79 |
Profit & loss (annual)
Annual · last column is TTM · ₹ Cr · tap + to expand
| Metric | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|---|---|
| Sales | 301 Cr | 333 Cr | 365 Cr | 445 Cr | Sign in for TTM |
| Operating expenses (approx.) | 253 Cr | 279 Cr | 310 Cr | 379 Cr | Sign in for TTM |
| EBITDA | 49 Cr | 53 Cr | 55 Cr | 66 Cr | Sign in for TTM |
| OPM % | 16.2% | 16.0% | 15.0% | 14.9% | Sign in for TTM |
| Other income | 0.55 Cr | 0.63 Cr | 5 Cr | 8 Cr | Sign in for TTM |
| Interest | 10 Cr | 9 Cr | 10 Cr | 16 Cr | Sign in for TTM |
| Depreciation | 3 Cr | 3 Cr | 4 Cr | 4 Cr | Sign in for TTM |
| Profit before tax | 36 Cr | 42 Cr | 41 Cr | 46 Cr | Sign in for TTM |
| Tax % | 3.2% | 4.7% | 4.9% | 10.1% | Sign in for TTM |
| Net profit | 35 Cr | 40 Cr | 39 Cr | 42 Cr | Sign in for TTM |
| EPS (₹) | ₹18.42 | ₹21.34 | ₹20.14 | ₹20.98 | Sign in for TTM |
| Dividend payout % | 10.9% | -9.6% | 9.8% | 9.1% | Sign in for TTM |
Trailing twelve months totals and margin rows
Balance sheet
Annual · ₹ Cr · tap + rows to expand
| Metric | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|
| Equity capital | 19 Cr | 19 Cr | 19 Cr | 19 Cr |
| Reserves | 562 Cr | 591 Cr | 625 Cr | 661 Cr |
| Borrowings | 105 Cr | 105 Cr | 110 Cr | 121 Cr |
| Other liabilities | 114 Cr | 165 Cr | 272 Cr | 296 Cr |
| Total liabilities | 793 Cr | 880 Cr | 1,026 Cr | 1,097 Cr |
| Fixed assets (net) | 234 Cr | 241 Cr | 243 Cr | 244 Cr |
| CWIP | 0.0000 Cr | 0.0000 Cr | 0.0000 Cr | 0.0000 Cr |
| Investments | 5 Cr | 9 Cr | 6 Cr | 6 Cr |
| Other assets | 521 Cr | 572 Cr | 690 Cr | 779 Cr |
| Total assets | 793 Cr | 880 Cr | 1,026 Cr | 1,097 Cr |
Cash flows
Annual · ₹ Cr · tap + rows to expand · last column includes FCF
| Metric | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|
| Cash from operating activity | 38 Cr | 70 Cr | 18 Cr | -13 Cr |
| Cash from investing | -3 Cr | -27 Cr | -4 Cr | 3 Cr |
| Cash from financing | -2 Cr | -5 Cr | -2 Cr | -4 Cr |
| Net cash flow | 34 Cr | 38 Cr | 11 Cr | -13 Cr |
| Free cash flow (OCF − Capex) | 36 Cr | 62 Cr | 10 Cr | -16 Cr |
Ratios
Ratios as reported or derived per annual period.
| Metric | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|
| ROCE % | 6.7% | 7.0% | 6.8% | 7.8% |
| ROE % | 6.1% | 0.0% | 0.0% | 0.0% |
| Debtor days | 118 | 103 | — | — |
| Inventory days | 645 | 590 | 546 | 536 |
| Days payable | 86 | 111 | — | — |
| Cash conversion cycle | 676 | 583 | 546 | 536 |
| Debt / equity | 0.18 | 0.17 | 0.17 | 0.18 |
| Current ratio | 2.41 | 2.18 | 1.89 | 1.97 |
| Net debt / EBITDA | 1.38 | 0.53 | 0.38 | 0.68 |
Compare with peers
Loading peers…